Trial Profile
Study of Two Tramadol Contramid OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2012
Price :
$35
*
At a glance
- Drugs Tramadol (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Altus Formulation Inc
- 07 Feb 2009 New trial record